Infinimmune Raises $75M To Advance Human Antibody Pipeline
· ventureburn.com
Infinimmune Raises $75M to advance antibody trials and expand its human-first discovery platform for new therapies in 2027 now on.
The company will advance two atopic dermatitis antibody candidates towards human trials in 2027.
Funding will also expand its Anthrobody platform and support n...